On March 2020, Hasharon hospital reopened as the first and solely COVID-19 hospital in Israel. For six weeks 52 positive COVID-19 patients were admitted to our ward, Corona B ward. According to previous publications, patients with coexisting hematological condition were more vulnerable to COVID-19 complications. In particular, corticosteroids treatment was reported to reduce the cytokine storm complication of COVID-19. Yet, the literature regarding corticosteroids treatment was controversial at that time. We present two positive COVID-19 hemato-oncologic patients with successful treatment with corticosteroids: a patient with active Chronic Lymphocytic Leukemia (CLL) and a patient with Hodgkin Lymphoma (HL). Epidemiological, clinical, laboratory, imaging and treatment course are discussed along with the relevant literature.
Keywords:
Published on: Nov 24, 2020 Pages: 28-33
Full Text PDF
Full Text HTML
DOI: 10.17352/ahcrr.000027
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."